MMP2 and neoplasm: Doxorubicin (DOX) was conjugated to the HPMA copolymer through a lysosomal cleavable linker and tumor-targeting and -penetrating peptide iRGD, which is selectively cleaved by MMP-2, an enzyme overexpressed in the prostate cancer microenvironment and closely linked to tumor progression [53].